Larvol Delta - MacroGenics-Provides-Phase-2-TAMARACK-Study-Early-Interim-Safety-Data-and-Plans-for-Future-Disclosures

vobramitamab duocarmazine (MGC018) - MacroGenics

https://www.globenewswire.com/news-release/2024/04/03/2857385/0/en/MacroGenics-Provides-Phase-2-TAMARACK-Study-Early-Interim-Safety-Data-and-Plans-for-Future-Disclosures.html

Apr 3, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next